OpenNeedle Ask your own

Question explored with the scientific record

How long can you feel under the weather from having Covid and flu jabs

Oct 7, 2026 · 5 sources used · OpenNeedle synthesis
The short version: most people feel rough for a day or two, but the studies here don't give you a clean single number, and the "under the weather" feeling can last longer for some.

The clearest data comes from a 2022 study of children with juvenile arthritis: after their mRNA shots, tiredness, muscle aches, headache, and fever were common, but all resolved within 1–2 days [3]. That matches the typical picture. A 2025 Sri Lankan study of working-age adults found symptoms were most common after the third dose, with about 6 in 10 people reporting something, but it doesn't state how long symptoms lasted [2]. A 2021 survey across three vaccines (Pfizer, AstraZeneca, Sinopharm) found mostly mild-to-moderate reactions, with a few unusual events lasting up to 13 days, like hand weakness or chest pain [1]. So the usual answer is 1–3 days, but outliers exist.

For flu shots, the only relevant study here is from 1983, testing an older subunit flu B vaccine. It found only mild local reactions and no systemic symptoms at all [4]. That's dated and doesn't reflect current flu vaccines, so treat it as weak evidence.

What's missing: no study here directly compares COVID and flu shots given together, and none tracks how long "under the weather" lasts in a general population with modern vaccines. The evidence is mostly short-term surveys, not rigorous trials with hard endpoints. The 2025 review linking spike protein persistence to long-term symptoms is speculative, not proof of duration [5].

My call: expect 1–3 days of feeling off after either shot, possibly longer after a booster, but the evidence for anything beyond that is thin. Confidence: moderate.

Keep digging

Sources used 5

  1. Safety of COVID‐19 vaccines Journal of Medical Virology (2021) Thin

    A cross-sectional survey of 1,736 adults in Iraq and Jordan assessed post-vaccination adverse effects after Pfizer-BioNTech, AstraZeneca, and Sinopharm vaccines, finding generally mild to moderate reactogenicity with Sinopharm showing comparatively fewer adverse effects and seve…

    DOI: 10.1002/jmv.27214
  2. Prevalence, severity and duration of post-vaccination symptoms following COVID-19 vaccination in a working-aged population in Galle district, Sri Lanka Ceylon Journal of Science (2025) Thin

    Post-vaccination symptoms are common among working-age adults in Galle District, Sri Lanka, peaking after the third COVID-19 vaccine dose and showing vaccine- and demographic-specific patterns.

    DOI: 10.4038/cjs.v54i1.8343
  3. Safety of the BNT162b2 mRNA COVID-19 vaccine in children and adolescents with juvenile idiopathic arthritis: a tertiary-center early experience Egyptian Rheumatology and Rehabilitation (2022) Thin

    A prospective cohort study of 36 children and adolescents with juvenile idiopathic arthritis found that the BNT162b2 mRNA COVID-19 vaccine was safe, producing mostly mild and transient local and systemic adverse events with no serious events and no disease flares.

    DOI: 10.1186/s43166-022-00143-z
  4. A graded-dose study of inactivated, surface antigen influenza B vaccine in volunteers: reactogenicity, antibody response and protection to challenge virus infection Journal of Hygiene (1983) primary study Strong

    In a randomized, blinded graded-dose trial, inactivated subunit influenza B vaccine was well tolerated and induced dose-dependent serum HI antibody; 20 or 40 microgram HA doses protected most volunteers against live attenuated RB77 challenge, with 50% protection at an HI titre o…

    DOI: 10.1017/s0022172400063907
  5. Do Long COVID and COVID Vaccine Side Effects Share Pathophysiological Picture and Biochemical Pathways? International Journal of Molecular Sciences (2025) Thin

    This review posits that long COVID and post-COVID vaccine–related symptoms may be driven by spike protein–mediated activation of three interlinked immuno-inflammatory pathways—renin-angiotensin-aldosterone system (RAAS), kallikrein-kinin system (KKS), and the lectin complement p…

    DOI: 10.3390/ijms26167879

Your question next

What do you want to know?

No question is too uncomfortable for the evidence. Bring yours.

Ask your question →